AP2S1 and familial hypocalciuric hypercalcemia: We confirmed the initial clinical diagnosis (biochemical data are shown in Table 3) of familial hypocalciuric hypercalcemia in 25% of the patients (17 out of the 66 patients had pathogenic or likely pathogenic variants in the CASR and AP2S1 genes).